Tomomi Nakamura
Saga, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Production of borneol, camphor, and bornyl acetate using engineered Saccharomyces cerevisiae.
Journal: Metabolic engineering communications
Published: November 19, 2024
A Phase 2 Single-Arm Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis NSCLC: Results for the First-Line Cohort of the OCEAN Study (LOGIK 1603/WJOG 9116L).
Journal: JTO clinical and research reports
Published: August 03, 2023
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study): primary analysis.
Journal: Therapeutic advances in medical oncology
Published: August 10, 2022
Factors related to the diagnosis of lung cancer by transbronchial biopsy with endobronchial ultrasonography and a guide sheath.
Journal: Thoracic cancer
Published: August 05, 2022
Anti-cancer effect of afatinib, dual inhibitor of HER2 and EGFR, on novel mutation HER2 E401G in models of patient-derived cancer.
Journal: BMC cancer
Published: July 07, 2022
Prospective analysis of factors precluding the initiation of durvalumab from an interim analysis of a phase II trial of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small cell lung cancer in Japan (SAMURAI study).
Journal: Therapeutic advances in medical oncology
Published: April 07, 2022
High Incidence of C797S Mutation in Patients With Long Treatment History of EGFR Tyrosine Kinase Inhibitors Including Osimertinib.
Journal: JTO clinical and research reports
Published: January 05, 2021
A Low Body Mass Index Is Associated with Unsuccessful Treatment in Patients with Mycobacterium avium Complex Pulmonary Disease.
Journal: Journal of clinical medicine
Published: December 29, 2020
Acute Generalized Exanthematous Pustulosis Caused by Erlotinib in a Patient with Lung Cancer.
Journal: Case reports in oncology
Published: December 28, 2020
A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study).
Journal: Therapeutic advances in medical oncology
Published: November 10, 2020
Synthetic production of prenylated naringenins in yeast using promiscuous microbial prenyltransferases.
Journal: Metabolic engineering communications
Published: July 09, 2020
Last Updated: 09/26/2026